[BDRX] QoQ Quarter Result on 31-Mar-2024 [#Q1]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Mar-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 5.81%
YoY- 7.29%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 42 42 149 149 116 -
PBT -1,717 -1,717 -1,815 -1,815 -1,928 -1,928 -2,545 -23.09%
Tax 63 63 59 59 144 144 248 -59.92%
NP -1,654 -1,654 -1,756 -1,756 -1,784 -1,784 -2,298 -19.70%
Tax Rate - - - - - - - -
Total Cost 1,654 1,654 1,797 1,797 1,933 1,933 2,413 -22.27%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -4,230.12 -4,230.12 -1,197.32 -1,197.32 -1,989.18 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -5.04 -5.04 -32.97 -1.32 -7.19 -7.19 -185.31 -90.97%
EPS Diluted -5.04 -5.04 -32.97 -1.32 -7.19 -7.19 -185.31 -90.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.